Send to

Choose Destination
See comment in PubMed Commons below
Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):835-45.

Summary of randomized trials of angiotensin converting enzyme inhibitors.

Author information

Division of Cardiology, McMaster University and The Hamilton Health Sciences Corporation Research Centre, Ontario, Canada.


Angiotensin converting enzyme (ACE) inhibitors have been shown to reduce the risk of death, worsening heart failure and recurrent infarction in patients with left ventricular dysfunction and heart failure. They have also been shown to reduce mortality in the acute phase of myocardial infarction. They have been demonstrated to reduce major vascular events and progression of renal disease in diabetes with hypertension, compared to placebo and to calcium channel blockers. Current trials are evaluating their role in preventing major vascular events in patients with coronary artery disease, strokes and Type II diabetes who are normotensive.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center